A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.

NCT07069972 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
180
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Yipeng Liu

Collaborators